Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Need More Women For Device Trials? Create Better Consent Forms, FDA Says

This article was originally published in The Gray Sheet

Executive Summary

Enrolling women and minorities in device trials remains a challenge. One potential solution highlighted at a recent FDA meeting: improve communication of potential treatment risks.

You may also be interested in...



Regulatory News In Brief

FDA releases de novo guidance

Regulatory News In Brief

FDA releases de novo guidance

FDA Panel: Transvaginal Mesh For Prolapse Should Be Class III

Current and future surgical mesh devices for pelvic organ prolapse repair would require PMA submissions under a recommendation last week by FDA’s Obstetrics and Gynecology Devices panel.

Related Content

Topics

UsernamePublicRestriction

Register

MT030589

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel